Search for: "Matter of Regen" Results 181 - 200 of 214
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Mar 2019, 3:26 pm
” Andrea Rossi reflects on when Pringles, drunk cart drivers, wine, art, and trade mark law come into contact.PatentsGuestKat Rose Hughes takes a look at the recent application of the Actavis case in the High Court case Regen Lab v Estar [2019] EWHC 63, where the Actavis questions were applied to a numerical value for the first time.InternKat Jonathan Pratt also looks at the application of Actavis in "Formstein defence in the UK? [read post]
6 Apr 2019, 9:46 am
| Applying the Actavis questions to numerical limitations: Regen Lab v Estar | Formstein defence in the UK? [read post]
27 Mar 2019, 11:33 am
| Applying the Actavis questions to numerical limitations: Regen Lab v Estar | Formstein defence in the UK? [read post]
23 Dec 2011, 6:53 pm by Andres
Reports Regenerative Medicine Goverence: The EU Experience and Argentine Possibilities Shawn H E Harmon, pp.323-328 | HTML | PDF | Can We Trust the Media? [read post]
12 Feb 2024, 3:33 pm by Dean I Weitzman, Esq.
An important area of research is regenerative medicine. [read post]
13 Apr 2019, 12:25 pm
| Applying the Actavis questions to numerical limitations: Regen Lab v Estar | Formstein defence in the UK? [read post]
29 Jan 2013, 6:18 pm by David Jensen
The public in general, including grant applicants, continues to have the right under state law to address the board on grant applications or any other matter they wish. [read post]
17 Apr 2013, 1:15 pm by Eric Alexander
  We have sometimes argued that the apparent tension is really a matter of whether the plaintiff has the proof needed based on a subsequent determination by FDA. [read post]
1 Jun 2016, 11:08 am by David Jensen
In his first and only lobbying appearance before his former board, Klein was successful in winning approval of a $20 million award to the firm despite the fact that it was rejected twice by the blue-ribbon reviewers of the California Institute for Regenerative Medicine(CIRM), as the agency is formally known. [read post]
5 Feb 2021, 4:58 am by Rose Hughes
The material from which the teapot was made would thus not matter for achievement of the non-drip feature. [read post]
17 Sep 2020, 6:14 am by David Jensen
The measure would give the agency, officially known as the California Institute for Regenerative Medicine (CIRM), $5.5 billion more and expand its scope of activities and research. [read post]
2 May 2018, 1:10 am by Jelle Hoekstra
Notice of opposition was filed against the granted patent, the opponent requesting revocation of the patent in its entirety on the grounds of lack of novelty and inventive step (Articles 54(2) and 56 EPC and Article 100(a) EPC), lack of sufficiency of disclosure (Article 100(b) EPC) and added subject-matter (Article 100(c) EPC).III. [read post]
2 May 2018, 1:10 am by Jelle Hoekstra
Notice of opposition was filed against the granted patent, the opponent requesting revocation of the patent in its entirety on the grounds of lack of novelty and inventive step (Articles 54(2) and 56 EPC and Article 100(a) EPC), lack of sufficiency of disclosure (Article 100(b) EPC) and added subject-matter (Article 100(c) EPC).III. [read post]
9 Nov 2019, 4:09 pm by INFORRM
Reisch, who sits in the Missouri House of Representatives, blocked Campbell for retweeting criticism of Reisch’s position on a matter of public interest. [read post]
6 Feb 2023, 7:43 pm by Guest Contributor
Here are a few of our key takeaways:  Representation matters. [read post]
31 Aug 2020, 3:00 am by David Jensen
Unless voters provide $5.5 billion more, the agency — known officially as the California Institute for Regenerative Medicine (CIRM) — will begin shutting its doors this winter. [read post]